Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...
PYNNACLE enrolled heavily pretreated TP53 Y220C–mutant ovarian cancer (median four prior lines), including platinum-resistant ...
The ability of different genetic variants—changes to one or more building blocks of DNA—to cause disease, and to what extent, ...
Heterogeneity in the thickness of the heart wall, represented by wall thickness standard deviation, can improve the early ...
Along with Gold and Rainbow, we now have the Silver Mutation. It was added to Grow a Garden alongside the Beanstalk Event, giving us yet another mutation that can apply to our crops. If you haven't ...
A fresh and important book reveals the messy reality of our ever-mutating cells – and why the quest to defeat ageing is ...
I decided to keep my healthy breast, opting against reconstruction. It means I'm now what's known in the community as a ...
Dr. Rachel N. Grisham presented findings at the 2026 Society of Gynecologic Oncology Annual Meeting showing that the ...
Researchers at the Manchester Institute of Biotechnology (MIB) have used engineering biology—an emerging technology that uses ...
Trial met all primary and key secondary endpoints, including progression-free survival and overall survival Company intends to include these data ...
Mutations in a key protein make a yeast found in dogs with common outer ear infections more resistant to the topical ...
University of Virginia School of Medicine scientists have used a next-generation form of gene editing to fix the underlying cause of a severe form of epilepsy in lab mice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results